Specification :

Everyone knows what the stomach does; but few people could explain the physiological functions and digestion procedures of the stomach. That¡¯s why so many people suffer from stomach disorders while few recover.

The small intestine shall be considered when the stomach is to be studied, as they make the complete process of digestion and absorption, that is, the stomach digests and the small intestine absorbs.

Food stimulates peristalsis of the stomach and secretion of gastric juice (or gastric acid as popularly known) which is mixed with food. The stomach makes the food a mixture, which is gradually sent into the duodenum.

Without digestion and absorption in the stomach and small intestine, there would be no energy supply to the human body. The stomach is thought of as ¡°mother of organs¡±. Many aged people die of malnutrition, as they demand less food with reduced activities. In addition, decayed teeth and degenerated digestion and absorption also contribute to malnutrition. Keeping the body health starts with keeping the stomach healthy.

The stomach wall and the intestinal wall are of similar structure. Their inner layer is made of the mucosa tissue rich in blood vessels, lymphatic vessels and nerves. Filled with food, the mucosa tissue is made stretched and smoothed; with empty stomach or small intestine, it is wrinkled¡ªsimilar to the skin of the old. The outer layer is made of smooth muscles. It is often mentioned that stomach and intestinal disorders occur in the mucosa tissue instead of in the smooth muscles. Simply stated, to protect the digestive system is to protect the mucosa tissue.

The mucosa tissue of the stomach and small intestine is easily destroyed. A few causes explain why so many people suffer from stomach disorders.

Caffeine in strong tea and coffee; tar and nicotine in cigarettes; antihistamine components in cold drugs, antiphlogistic agent.

Salmonella, staphylococcus aureus and helicobacter pylori in unclean foods.

Viruses for upper respiratory tract infection. I wonder if you have got the experience that the cold is often accompanied by diarrhea.

Tension and stress due to anxiety.

Blood stagnation or oxygen shortage of the mucosa caused by poor heart function or blood circulation.

Among all the stomach and intestinal disorders, the most common is duodenal ulcer. The duodenum is a part of the small intestinal directly linked to pylorus at the lower outlet of the stomach, as long as twelve adult fingers placed side by side (about 25 cm).

When the paste-like food mixture containing gastric acid is gradually pushed into the duodenum, the alkaline intestinal juice secreted by the duodenal mocusa is unable to neutralize the gastric acid in the initial stage as the acid is strong. Thus, duodenal ulcer is easy to happen. How can one get to know whether he has got the disease or not? During its attack, one has a pain near the heart between two lines of ribs, similar to stabbing pains. In serious cases, the pain spreads to the back.

In short, prevention and treatment of stomach and intestinal disorders are carried out in three aspects, leading to complete control.

The wonder drug for stomach and intestinal disorders is Unaupatta.

UNAUPATTA has been marketed abroad for seven or eight years, whose efficacy in prevention and treatment has been widely accepted internationally. I am to explain how it works.

UNAUPATTA functions in three aspects¡ªantibacterial, improvement of immunity and promotion of blood circulation in stomach and intestinal mocusa.

Antibacterial

Helicobacter pylori and salmonella, two main causes for stomach and intestinal ulcers, destroy the mocusa tissue. UNAUPATTA is capable of effectively control their growth and reproduction.

In a laboratory test, stomach mocusa tissue and helicobacter pylori are placed into culture media. UNAUPATTA is added into one group and saline into the control group. Cultivate the two groups for 24 hours under the same condition and it is found that UNAUPATTA¡¯s antibacterial effect is 1.5 times that of saline. In another test, stomach mocusa tissue, helicobacter pylori and monocyt are used. The UNAUPATTA group and the saline group are cultivated for 24 hours under the same condition and it is found that UNAUPATTA¡¯s antibacterial effect is 2.5 times that of saline. It is proven that UNAUPATTA really protects the stomach and intestine by antibacterial functions. Mice are used in the third test. First, we apply ethanol (alcohol) to the stomach of mice, damaging the mocusa tissue. Four hours later, we apply UNAUPATTA to the treatment group and saline to the control group (twice a day). One hour after the second application, the mice are dissected and observed so that total damage area of stomach mocusa is calculated by bleeding spots. In the saline group, the total damage area is 17.8 m m2 and in the UNAUPATTA group, it is 3.85 m m2, with a difference of 4.62 times. Researches have proven that UNAUPATTA is definitely effective in treatment of bleeding ulcer.

Improvement of immunity

Improvement of immunity leads to inhibition of malignant tumors in the stomach and intestine. The human immunity depends on two immune systems¡ªcellular immune system and humoral (lymph fluid) immune system; the former is of much more importance. The cellular immune system includes macrophages and leucocytes. UNAUPATTA¡¯s effect upon macrophages is tested with mice. Phagocytosis (swallowing) of marcrophages upon germs or tumor cells indicates stronger or weaker immunity. The groups are involved in the test. In one group, UNAUPATTA is injected intraperitoneally and in the control group, saline is injected. The inject lasts for seven successive days. On the fifth day, chicken¡¯s red blood cell (RBC) liquid is injected intraperitoneally; Chicken¡¯s RBC liquid (blood) is an invader for the mice. Chicken RBC liquids and abdominal excudates are collected so as to check the index of phagocytosis (IP) and rate of phagocytosis of marcrophages upon chicken RBC. It is found that the index of phagocytosis of marcrophages in the UNAUPATTA group is 1.76 times that in the saline group and the rate of phagocytosis is 5.45 times. It is proven that UNAUPATTA significantly improves phagocytosis of marcrophages and immunity of the human body.

To confirm the correlation between improved immunity and resistance to stomach cancer and intestinal cancer, UNAUPATTA is tested in terms of resistance to tumors.

In the laboratory test, mouse sarcom cells are mixed with UNAUPATTA solutions in one group and with saline in the control group. Cultivated under 37oC for one hour, the culture is subcutaneously given to mice. Ten years later, examinations find no tumor cells in UNAUPATTA group and 2.16-g tumor cells in the saline group. UNAUPATTA is 100% effective in inhibition of tumor cells.

Promotion of blood circulation in mocusa

The stomach and intestinal mocusa is rich in blood capillaries. Blood flow of capillaries is an indicator for physiological functions of the stomach and intestine. When functioning well, the stomach and intestine are less likely to have ulcers and more likely to recover from ulcers. In addition, they absorb nutrients better.

In the test, dogs of 10 kg are used. Carry out phenobarbital intravenous injection, anesthesia and dissection and observe blood flow in mocusa before use of UNAUPATTA. Then, inject intravenously UNAUPATTA solution (1 ml / kg) and observe the difference in blood flow. It is observed that blood flow slows down soon after injection of UNAUPATTA, which returns to normal 5 minutes later. In 10 minutes, blood flow accelerates, which becomes significant in 15 minutes. The increase in blood flow remains until after one hour. It is proven that UNAUPATTA is significantly effective in treatment of gastric ulcer and gastritis. As mentioned above, poor heart function or blood flow lead to blood stagnation or oxygen shortage of the stomach and intestine, making patient more vulnerable to gastritis and gastric ulcer. So we use ex-vivo hearts of guinea pigs to test UNAUPATTA¡¯s influence upon blood flow in coronary arteries. The UNAUPATTA solution is applied to hearts of guinea pigs in three independent tests. It is found that the output of coronary arteries is 5.2 ml/minute before the test and 16.6 ml/minute after the test, an increase of 2.1 times. It proves that UNAUPATTA reinforces the heart, which reduces risks of gastric and intestinal disorders.

UNAUPATTA functions in three aspects¡ªantibacterial, improvement of immunity and promotion of blood circulation in stomach and intestinal mocusa¡ªare clearly explained.

In addition, UNAUPATTA promotes intestinal peristalsis and accelerates food movement in the small intestine, reducing food deposit and deterioration and thus risks of gastric and intestinal disorders. UNAUPATTA is an overall and first-class health food for prevention and treatment of diseases.

If use of Hsen chii products leads to no improvement, it is certain that the user has got gastric and intestinal disorders, unable to absorb efficiently. It is advised that he should use UNAUPATTA.